Today: 20 March 2026
Browse Category

NASDAQ:CGOI 9 January 2026

CG Oncology stock jumps 25% after pulling Phase 3 PIVOT-006 bladder cancer data into 1H 2026

CG Oncology stock jumps 25% after pulling Phase 3 PIVOT-006 bladder cancer data into 1H 2026

CG Oncology shares surged 25.1% to $52.45 after the company advanced the expected release of late-stage bladder cancer trial results to the first half of 2026. The PIVOT-006 Phase 3 trial enrolled over 360 patients and compares cretostimogene grenadenorepvec to surveillance after tumor removal. Trading volume topped 4.1 million shares by midday. Morgan Stanley raised its price target on the stock to $89.

Stock Market Today

  • Smiths Group Shares Fall 6% Despite Strategic Sales and Capital Returns
    March 20, 2026, 7:37 AM EDT. Shares of Smiths Group (LSE:SMIN) dropped 5.9% to 2,222p following mixed half-year results and slightly lowered full-year guidance. The company saw organic revenue growth of 4% and a 7.2% rise in headline operating profit to £248 million, with margins improving 50 basis points to 17.2%. However, statutory profits fell sharply due to one-off charges, causing a 17.4% drop in earnings per share. CEO Roland Carter highlighted the sale of Smiths Detection and Smiths Interconnect as transformational, alongside a £1.5 billion planned shareholder return through 2027. Analysts noted investor disappointment over modest revenue growth and trimmed guidance, despite a 5.4% dividend increase. Long-term outlook remains positive with disposals, acquisitions, and capital returns aiming for mid-term 5-7% organic growth and 21-23% margins, seen as a potential buying opportunity by some market watchers.
Go toTop